|
|
O Einarsson, G P Geba, Z Zhu, M Landry, J A Elias
J Clin Invest. 1996;
97(4):915
doi:10.1172/JCI118514
Abstract |
Full text
| PDF

T
o address the role of IL-11 in viral airways dysfunction, we determined whether infectious agents that exacerbate asthma stimulate stromal cell IL-11 production, determined whether IL-11 could be detected at sites of viral infection and evaluated the effects of IL-11 on airway physiology. Respiratory syncytial virus (RSV), parainfluenza virus type 3 (PIV3), and rhinovirus (RV) 14 were potent stimulators while cytomegalovirus and adenovirus only weakly stimulated and herpes simplex virus type 2 and bacteria did not stimulate IL-11 elaboration. IL-11 was not detected or barely detected in nasal aspirates from children without, but was detected in aspirates from children with viral upper respiratory tract infections. The levels of IL-11 were highest in patients with clinically detectable wheezing. IL-11 also caused nonspecific airways hyperresponsiveness in BALB/c mice. These studies demonstrate that three major causes of viral-induced asthma, RSV, RV, and PIV, in contrast to other viruses and bacteria, share the ability to induce stromal cell IL-11 production. They also demonstrate that IL-11 can be detected in vivo during viral respiratory infections, that the presence of IL-11 correlates with clinical bronchospasm and that IL-11 is a potent inducer of airways hyperresponsiveness. IL-11 may be an important mediator in viral airways disorders.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(58)
| Title and authors |
Publication |
Year |
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Mübeccel Akdis, Simone Burgler, Reto Crameri, Thomas Eiwegger, Hiroyuki Fujita, Enrique Gomez, Sven Klunker, Norbert Meyer, Liam O’Mahony, Oscar Palomares, Claudio Rhyner, Nadia Quaked, Anna Schaffartzik, Willem Van De Veen, Sabine Zeller, Maya Zimmermann, Cezmi A. Akdis
|
Journal of Allergy and Clinical Immunology
|
2011 |
Epithelial cells and airway diseases
David Proud, Richard Leigh
|
Immunological Reviews
|
2011 |
MAPK- and PKC/CREB-dependent induction of interleukin-11 by the environmental contaminant formaldehyde in human bronchial epithelial cells
Valérie Lecureur, Matthieu Arzel, Sarah Ameziane, Noémie Houlbert, Marc Le Vee, Stéphane Jouneau, Olivier Fardel
|
Toxicology
|
2011 |
The role of viruses in acute exacerbations of asthma
David J. Jackson, Sebastian L. Johnston
|
Journal of Allergy and Clinical Immunology
|
2010 |
Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: Regulation of the type-II IL-4 receptor chains IL-4Rα and IL-13Rα1
Dominik K. Fritz, Christine Kerr, Fernando Botelho, Martin Stampfli, Carl D. Richards
|
Experimental Cell Research
|
2009 |
Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease
Michael R. Edwards, Nathan W. Bartlett, Deborah Clarke, Mark Birrell, Maria Belvisi, Sebastian L. Johnston
|
Pharmacology & Therapeutics
|
2009 |
Infections
Simon D. Message, Sebastian L. Johnston
|
Asthma and COPD
|
2009 |
Cytokines
Kian Fan Chung
|
Asthma and COPD
|
2009 |
Understanding the mechanisms of viral induced asthma: New therapeutic directions
Nicole G. Hansbro, Jay C. Horvat, Peter A. Wark, Philip M. Hansbro
|
Pharmacology & Therapeutics
|
2008 |
Attenuation of the type I interferon response in cells infected with human rhinovirus
Swathi Kotla, Tao Peng, Roger E. Bumgarner, Kurt E. Gustin
|
Virology
|
2008 |
|